agilon health, inc.

Análisis de la acción agilon health, inc. (AGL)

$90.290

-0.695 (-0.77%)Al cierre

Loading chart…
Máximo
93.150
Apertura
89.710
Precio medio ponderado por volumen
90.38
Volumen
184.31K
Capitalización
2.71B
Mínimo
87.690
Importe
16.66M
EV/EBITDA, TTM
13.43

agilon health, inc. is a healthcare company. The Company operates a Medicare-centric, capitated line of business. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing monthly payments to manage the total healthcare needs of its physician partners attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform supports the transition to a Total Care Model with technology, people, process and capital.

Análisis de IA of agilon health, inc. (AGL)

Comprar

Agilon Health is a good buy right now due to its recent positive earnings report showing a Q2 revenue of $1.49 billion, exceeding expectations, and an adjusted EPS of $2.15, far above the estimate of $0.27. The stock is currently priced at $85.12, with a significant upside potential as analysts have set a price target of $125, representing a potential upside of 47%.

Métricas de valoración

El PER previsto actual de agilon health, inc. (AGL) es 178.57, frente a su media de 5 años de 28.74.

PER previsto

Valor razonable
Media 5A P/E
28.74
P/E actual
178.57
Sobrevalorada
321.57
Infravalorada
-264.10

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
149.57
EV/EBITDA actual
13.43
Sobrevalorada
588.22
Infravalorada
-289.09

Precio/ventas previsto

Valor razonable
Media 5A P/S
1.15
P/S actual
0.25
Sobrevalorada
2.37
Infravalorada
-0.07

Escenarios de precio de Alphio AI para AGL

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%AGL

$3.37

Precio del escenario

B

Base

Base · 50%AGL

$3.18

Precio del escenario

B

Bajista

Bajista · 25%AGL

$2.51

Precio del escenario

Ballenas con AGL en cartera

I

IOOF Investment Management Limited

+ Con en carteraAGL

-2.84%

Rentabilidad a 3 meses

N

Nt-Comnwlth Super Corp

+ Con en carteraAGLCSL

-3.62%

Rentabilidad a 3 meses

D

Durable Capital Partners, LP

+ Con en carteraAGL

-7.66%

Rentabilidad a 3 meses

R

Rock Springs Capital Management LP

+ Con en carteraAGL

-9.60%

Rentabilidad a 3 meses

Cronología de eventos

2026-09-30 (ET)

09:30:00

Agilon Health Expands Partnership with The Jackson Clinic

2026-09-23 (ET)

09:30:00

Agilon Health Expands Partnership with Springfield Clinic

2026-09-10 (ET)

09:30:00

Agilon Health Expands Partnership with Family Practice Center

2026-08-05 (ET)

17:00:00

agilon health Q2 Revenue $1.49B, Exceeds Expectations

17:00:00

Sees Q3 Adjusted EBITDA at -$5M

Noticias

Preguntas frecuentes sobre AGL, respondidas por Alphio AI

agilon health, inc. is a healthcare company. The Company operates a Medicare-centric, capitated line of business. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing monthly payments to manage the total healthcare needs of its physician partners attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform supports the transition to a Total Care Model with technology, people, process and capital. It operates in the Healthcare sector (SERVICES-MISC HEALTH & ALLIED SERVICES, NEC industry).

Agilon Health is a good buy right now due to its recent positive earnings report showing a Q2 revenue of $1.49 billion, exceeding expectations, and an adjusted EPS of $2.15, far above the estimate of $0.27. The stock is currently priced at $85.12, with a significant upside potential as analysts have set a price target of $125, representing a potential upside of 47%.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar